Corylin

ID: corylin

Aliases: Psoralea corylifolia flavonoid

Type: compound

Route/form: oral/preclinical dietary flavonoid context

Status: research

Evidence level: preclinical

Best data tier: non-human experimental

Support scope: non-human/mechanistic, review/regulatory

Source types: preclinical, review

Linked sources: 3

Broad outcomes: Fat loss / metabolic health, Longevity / mitochondrial / redox

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

Optimization domains

Research basis

Limits, risks, and missing evidence

Risk flags

Linked papers, labels, and reviews

  1. The flavonoid corylin exhibits lifespan extension properties in mouse
    preclinical / nature_corylin_lifespan_mouse_2022
    Mouse lifespan/metabolic-health source for corylin; high-fat-diet model, not human longevity evidence.
  2. Corylin Inhibits Vascular Cell Inflammation, Proliferation and Migration and Reduces Atherosclerosis in ApoE-Deficient Mice
    preclinical / pubmed_corylin_atherosclerosis_mouse_2020
    Corylin vascular-inflammation/atherosclerosis mouse and cell source; useful related anti-inflammatory/metabolic-aging mechanism context.
  3. A review of Psoralea corylifolia L.: a valuable plant with profound biological significance
    review / frontiers_psoralea_review_2025
    Botanical-source review covering Psoralea corylifolia phytochemistry, pharmacology, processing, and hepatotoxicity/safety context.